Tag: CPAP Device
ResMed announces strategy, outlook
October 1, 2024HME News Staff
SAN DIEGO – ResMed unveiled its 2030 strategy to drive growth, profitability and shareholder returns, including investing 7% in R&D, at an Investor Day in New York City.
The company also announced its five-year revenue and earnings growth outlook, reflecting its plans to accelerate product and technology innovation, operational excellence, commercial execution and financial strength.
“By building on our leadership in connected digital health, our 2030 Strategy will further...
Providers sue Philips for cutting them off
July 16, 2024HME News Staff
PHILADELPHIA – Dynamic Healthcare Services and Hometown Oxygen Pittsburgh on July 15 filed a lawsuit against Philips Respironics, DeLage Landen Financial Services and Philips Medical Capital for cutting off access to financing and leasing programs that the providers say are necessary for them to compete.
According to the lawsuit, filed in the U.S. District Court for the Eastern District of Pennsylvania:
Prior to the Philips recall, DHS purchased thousands of respiratory...
Researchers develop new CPAP design
July 9, 2024HME News Staff
CINCINNATI – Researchers at the University of Cincinnati are developing a PAP machine that uses vortex airflow technology, a mechanism commonly used in aerospace engineering applications, to eliminate the need for a tight seal. As a result, the VortexPAP is able to use a mask that is designed to barely touch the patient’s face, increasing comfort, researchers say. “Despite the clinical efficacy for CPAP in controlling OSA, patient compliance with the therapy remains a major cause...
Philips wants SoClean to pay part of settlement
May 16, 2024HME News Staff
PITTSBURGH – Philips has sued SoClean in a bid to get the company, whose ozone cleaners it says “attacks” the foam in its CPAP devices, to pay part of its recently announced $1.1 billion settlement.
Philips announced the settlement in April to resolve the personal injury litigation and the medical monitoring class action related to a recall of certain sleep and respiratory devices in the U.S.
“(SoClean’s) negligent and intentionally misleading...
Philips has ‘finality’
May 1, 2024Liz Beaulieu, Editor
AMSTERDAM – Philips has a renewed focus, says CEO Roy Jakobs, now that the company has resolved additional settlements and finalized a consent decree related to a large recall of certain devices in its Sleep and Respiratory Care business unit.
The company recently announced that it has agreed to pay $1.1 billion from its cash flow generation to resolve personal injury litigation and medical monitoring class action in the U.S. This follows an economic loss settlement finalized last...
Survey finds improving supply for CPAP devices
March 18, 2024HME News Staff
NEW YORK – Respondents saw a 6% increase in sleep patient volume, on average, in the last 12 months, according to the HME Sleep and Oxygen Survey for the first quarter of 2024 from Needham and Co.
Respondents expect 6.5% growth in the next 12 months.
“We suspect that the increase is due to improving flow generator supply and HMEs engaging both new and backlogged patients that resulted from the Philips Respironics recall,” the report stated.
Other...
In brief: React Health and Rotech CEOs, Philips medical device reports
February 7, 2024HME News Staff
SARASOTA, Fla. – React Health has appointed Bill Shoop, most recently vice president and general manager of ResMed North America, as its CEO.
“I am extremely excited about the opportunity to join this experienced and talented team,” he said. “I believe React Health is very well positioned to help the industry and continue to advance our mission of delivering innovative solutions that positively impact patients’ lives and the people that care for them.”
Shoop,...
ResMed starts tracking patients on both weight loss drugs, CPAP therapy
January 5, 2024Liz Beaulieu, Editor
YARMOUTH, Maine – ResMed CEO Mick Farrell believes that, based on the company’s early research, weight loss drugs will be a “net positive” for patient flow for sleep apnea.
“I mean, I think there's $1 trillion worth of market cap now from these (pharmaceutical) companies and they will turn that into marketing to bring people in for the miracle drug,” he said during a recent conference call to discuss ResMed’s latest financial results. “And...
Philips reaches settlement related to CPAP recall
September 7, 2023HME News Staff
AMSTERDAM – Royal Philips has announced that the company and certain U.S. subsidiaries, including Philips Respironics, have reached an agreement to resolve all economic loss claims related to a voluntary recall of certain sleep and respiratory care devices.
The agreement, which is expected to be submitted to the U.S. District Court for the Western District of Pennsylvania later today and which is subject to that court’s approval, will provide predefined cash awards to all eligible...
CPAP recall: When it comes to regaining trust, Philips has work to do
June 9, 2023Theresa Flaherty, Managing Editor
YARMOUTH, Maine – Two years after a recall wreaked havoc on the CPAP market, things have stabilized, but providers have mixed reviews on the way Philips handled the situation.
Philips first announced the recall of certain CPAP devices and ventilators in June 2021, sending providers on a rollercoaster of device shortages, confused patients, communication missteps and even recalls of reworked devices.
“Would I deal with Philips again?” said Tyler Riddle, president...